News

C4IP Publishes Pro-Innovation Government Agenda to Promote U.S. Innovation

C4IP Sets Out Pro-IP Agenda for Congress and Trump Admin

Senate Panel Advances Bills Tackling Drug Patents, Pricing

Senate Judiciary Committee to Consider Bills Targeting Pharma Patents and Pricing

Former USPTO director says AI ‘not a debate,’ all works need protections

Nokia, Amazon settlement keeps USITC views on SEPs under wraps for now

ITC Hears Strong Views On Import Bans For Essential Patents

POLITICO Influence: John Cabeca Joins C4IP

2 MIKES LIVE #193: IP and Innovation with Andrei Iancu

C4IP Urges Passage of PERA, Other Patent Reforms to Augment NSF’s AI Action Plan

Squires’ Breadth Sets Him Apart From Recent USPTO Leaders

White House Urged To Back Patent Eligibility Bill To Aid AI

Scroll to Top